Myelin Oligodendrocyte Glycoprotein (MOG) (Middle Region) Peptid
Kurzübersicht für Myelin Oligodendrocyte Glycoprotein (MOG) (Middle Region) Peptid (ABIN5511354)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Sequenz
- VELPCRISPG KNATGMEVGW YRPPFSRVVH LYRNGKDQDG DQAPEYRGRT
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- MOG Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
-
Hintergrund
-
The product of this gene is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, it is a primary target antigen involved in immune-mediated demyelination. This protein may be involved in completion and maintenance of the myelin sheath and in cell-cell communication. Alternatively spliced transcript variants encoding different isoforms have been identified.
Alias Symbols: BTN6, BTNL11, MOGIG2, NRCLP7
Protein Size: 208 -
Gen-ID
- 4340
-
NCBI Accession
- NM_001008228, NP_001008229
Target
-